LUPRON DEPOT (leuprolide acetate for depot suspension) has helped treat advanced prostate cancer for over 35 years. Find out if treatment is right for you.
to be better than IMRT. A more focused form of radiation, stereotactic radiation, is being used for early forms of prostate cancer. This treatment also has not been shown to improve the outcome of prostate cancer. Though it may take less time than IMRT, it may have more side effects. ...
Treatments such as surgery and radiation are invasive, with potential side effects and complications (Wilt 2017; Lee 2015). Men with low-risk prostate cancer have a good chance of living full lives without being affected by the disease, even without active treatment (Wilt 2017; Hamdy 2016). ...
Prostate cancer is comprised nearly always of adenocarcinomacells -- cells that arise from glandular tissue. Cancer cells are named according to the organ in which they originate no matter where in the body we find such cells. Thus, if prostate cancer cells spread in the body to the bones, ...
effects of undetected/untreated prostate cancer. Conversely, men over 70 often have more indolent or slow-growing prostate cancers or other medical conditions that may be greater threats to their lives over the next 10 years than may prostate cancer, and thus less aggressive evaluation and ...
Degarelix(Firmagon) is a LHRH antagonist used to treat advanced prostate cancer. It has been shown to decrease the progression of disease, but further trials are needed to look at long-term outcomes. It is fairly well tolerated with common side effects being local injection site problems and in...
James went to Singapore to consult an urologist at a private hospital. A bone scan showed his prostate cancer had spread to his bones. James was given Lucrin injection (three months once) and an oral drug, Casodex. Three months later, the doctor increased the Casodex dosage because his PSA...
in combination or in conjunction with additional agents, preferably anti-cancer agents. For example, in one embodiment the anti-cancer agent is administered separately by injection and the compound of the invention is administered orally, concurrently or sequentially with taxane and/or glucocorticoid hor...
Androgen deprivation is a conventional therapy to treat prostate cancer. Androgen blockade can be achieved through several different routes. Androgen suppressive drugs include, e.g., Lupron (leuprolide acetate), Casodex (bicalutamide), Eulexin (flutamide), Nilandron (nilutamide), Zoladex (goserelin acet...
Prostate cancer remains the second-most frequently diagnosed cancer among men worldwide with estimated 1.1 million new cases per year. Moreover, with expected 307,000 deaths, it represents the fifth leading cause of cancer deaths. Whereas primary tumors can successfully be treated, there is no cur...